Rebuttal Letters Issued to Shareholders of NYMOX PHARMACEUTICAL CORP

WHAT:  Following the distribution of a press release by Nymox Pharmaceutical Corporation (the Company) regarding a NASDAQ Hearing Delist Decision at the open of business on July 7, 2023, rebuttal letters are being issued to all Company shareholders. Access the documents at www.crnsv.com WHAT:   Following the distribution of apress releaseby Nymox Pharmaceutical Corporation (the Company) regarding a NASDAQ Hearing Delist Decision at the open of business onJuly 7, 2023, rebuttal letters...

WHAT:  Following the distribution of a press release by Nymox Pharmaceutical Corporation (the Company) regarding a NASDAQ Hearing Delist Decision at the open of business on July 7, 2023, rebuttal letters are being issued to all Company shareholders. Access the documents at www.crnsv.com

When:  July 10, 2023

Where:  CARSON CITY, Nevada; LONDON

Why:  Summary of Rebuttal Letters: 

View original content:https://www.prnewswire.co.uk/news-releases/rebuttal-letters-issued-to-shareholders-of-nymox-pharmaceutical-corp-301873345.html